Xcout Intel
Caldera Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Caldera Therapeutics among drug discovery companies — ranked by similarity to what Caldera Therapeutics actually does, not by market-cap band.
Subscribe to see Caldera Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Caldera Therapeutics
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Caldera Therapeutics at a glance
Caldera Therapeutics is a drug discovery company headquartered in United States. Its most recent funding round, Series A, raised $75M in January 2026. Xcout tracks 6 named people at Caldera Therapeutics, including Praveen Tipirneni (Chief Executive Officer).
Caldera Therapeutics leadership
- Praveen TipirneniChief Executive Officer
- Praveen TipirneniExecutive Officer
- Aaron RoystonDirector
- Michael GladstoneDirector
- Michelle DoigDirector
- Xiaodi SuDirector
Caldera Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $75M | 6 named | |
| Series A-1 | $75M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Caldera Therapeutics news
Top 12 Caldera Therapeutics competitors
Ranked by semantic similarity — how close each company is to Caldera Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Similar drug discovery company
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Similar drug discovery company
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Similar drug discovery company
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar drug discovery company
META Pharmaceuticals Inc. is a pioneering biotechnology company focusing on immuno-metabolism and gastrointestinal therapeutics within immunology, operating research efforts connected to JLABS in Shanghai.
Similar drug discovery company
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Biopharmaceutical
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops novel, immune-mediated therapies designed to treat inflammatory and blinding diseases. Their proprietary technology platform leverages glycobiology to modulate the immune system for patient benefit.
Biopharmaceuticals
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Biopharmaceutical
Createrna, Inc. is an innovative biopharmaceutical company dedicated to the discovery and development of treatments for immunology, respiratory, and cardiovascular diseases. The company focuses its research pipeline on addressing complex chronic conditions through targeted therapeutic approaches. Their portfolio highlights early-stage pharmaceutical developments in specialized medical fields.
Biopharmaceuticals
Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company based in Burlington, Massachusetts, focused on developing antibody-drug conjugates (ADCs).
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Caldera Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Caldera Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →